Vaccine-associated sarcoma is a rare but serious cancer that develops at injection sites in cats. Understanding risk factors and proper injection protocols reduces incidence and enables early detection.
Vaccine-associated sarcoma causes significant suffering through tumor growth, local invasion, potential metastasis, and the consequences of aggressive treatment including amputation and radiation therapy. The welfare dilemma is that the vaccines causing risk also protect against life-threatening diseases. The ethical approach is using risk-benefit analysis to give only necessary vaccines at appropriate intervals, using the recommended anatomical sites, monitoring injection sites systematically, and acting quickly when suspicious lesions appear. Early detection and aggressive surgery offers the best welfare outcome.